Summary
An original electron-capture gas chromatographic assay was developed for simultaneous measurement of plasma levels of the benzodiazepine derivative prazepam and of its principal unconjugated metabolite, N-desmethyldiazepam. The assay was used to study the pharmacokinetics of the drug and its comparative bioavailability from tablets and from a specially prepared solution. Nine healthy adult volunteers were studied. Each volunteer on one occasion took 30 mg of the drug in tablet form, and on another occasion 30 mg of the drug in solution. In all subjects, N-desmethyldiazepam appeared in plasma shortly after prazepam appeared and reached a peak within four hours of prazepam ingestion. Thereafter plasma N-desmethyldiazepam levels were much higher than plasma prazepam levels throughout. Prazepam became undetectable within six hours of intake, whereas its metabolite could still be measured in plasma fourteen days after dosage. Thus much of the pharmacological action of prazepam may be mediated through its metabolite, N-desmethyldiazepam. In five of the nine subjects, areas under the plasma level curves for the metabolite were not markedly different for the tablet and solution formulations studied. In the other four subjects the area under the curve for the tablets was 50% to 80% of the area under the curve for the solution. The time to reach peak plasma level for the metabolite was shorter after the solution formulation (mean 2.0±SD 1.2 h) than after the tablet formulation (mean 4.2±SD 1.7 h).
Similar content being viewed by others
References
Biscaldi, G. P., Hattab, J., Montanaro, N., Scoz, R.: Quantitative polygraphic evaluation of emotional tension in the study of a new benzodiazepine. Curr. Ther. Res.13, 606–615 (1971)
Di Carlo, J. F., Viau, J. P., Epps, J. E., Haynes, L. J.: Biotransformation of prazepam in man. J. Pharmacol. Ther.11, 890–896 (1970)
Eustace, P. W., Hailey, D. M., Baird, E. S.: Biliary excretion of diazepam in man. Br. J. Anaesth.47, 983–985 (1975)
Gibaldi, M., Perrier, D.: in Pharmacokinetics, vol. 1. Drugs and the Pharmaceutical sciences. J. Swarbrick (ed.), pp. 293–296. New York, New York: Marcel Dekker, Inc. 1975
Greenblatt, D. J., Shader, R. I.: Benzodiozepines in clinical practice, p. 17. New York: Raven Press 1974
Greenblatt, D. J., Shader, R. I.: Prazepam, a precursor of desmethyldiazepam. Lancet1978 I, 720
Mahon, W. A., Inaba, T., Umeda, T., Tsutsumi, E., Stone, R.: Biliary elimination of diazepam in man. Clin. Pharmacol. Ther.17, 443–450 (1976)
Schwartz, M. A., Koechlin, B. A., Postma, E., Palmer, S., Krol, G.: Metabolism of diazepam in rat, dog and man. J. Pharmacol. Exp. Ther.149, 423–435 (1965)
Sellman, R., Hurme, M., Kanto, J.: Biliary excretion of diazepam and its metabolites in man after repeated oral doses. Eur. J. Clin. Pharmacol.12, 209–212 (1977)
Tansella, M., Burti, L., Siciliani, O., Zimmerman, C., Schiavon, M., Gerna, M., Tognoni, G., Morselli, P. L.: N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients: correlations between plasma levels and behavioural tests. Psychopharmacologia41, 81–85 (1975)
Tognoni, G., Gomeni, R., De Maio, D., Alberti, G. G., Franciosi, P., Scieghi, G.: Pharmacokinetics of N-desmethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br. J. Clin. Pharmacol.2, 227–232 (1975)
Tosi, G. C., Tosi, G. C., Hattab, J. R.: The use of N-desmethyldiazepam in outpatients suffering from insomnia. Curr. Ther. Res.15, 460–464 (1973)
Van der Kleijn, E.: Kinetics of distribution and metabolism of diazepam and chlordiazepoxide in mice. Arch. Int. Pharmacodyn. Ther.178, 193–215 (1969)
Vessel, E. L. S., Passananti, G. T., Viau, J. P., Epps, J. E., Di Carlo, F. G.: Effects of chronic prazepam administration on drug metabolism in man and rat. J. Pharmacol.7, 197–205 (1972)
Wagner, J. G.: in Biopharmaceutics and relevant pharmacokinetics, p. 295. Hamilton, Illinois: Hamilton Press 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, M.T., Evans, L.E.J., Eadie, M.J. et al. Pharmacokinetics of prazepam in man. Eur J Clin Pharmacol 16, 141–147 (1979). https://doi.org/10.1007/BF00563121
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563121